Inhibition of NF-κB signalling blocks osteoclastogenesis, which indicates the role of NF-κB in the RANKL-RANK signalling pathway and in establishing the bone-destructive microenvironment that occurs in MM [137]. Here, TNFRSF11A is linked to Miyoshi myopathy.